wellrank.ai
Bijuva logo

Bijuva

First cited by AI Jun 11, 2026
bijuvargheseassociates.com

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning Bijuva, through Jun 13, 2026.

8.3%

Avg position when mentioned: 5.0

By engine

Where Bijuva is strong, and where it is invisible.

  • ChatGPT
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 3 positive mentions
  • 0 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Bijuva

ChatGPTJun 13, 2026, 11:06 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Short answer “Bioidentical” hormones are molecules formulated to be chemically identical to the hormones your body makes (usually estradiol and progesterone). “Standard” HRT (hormone replacement therapy) includes both bioidentical (FDA‑approved) products and older synthetic or animal‑derived products; the main practical difference most people face is whether the product is an FDA‑reviewed drug or a custom‑compounded preparation from a pharmacy. There’s no good evidence that custom‑compounded “bioidentical hormone therapy” is safer or more effective than FDA‑approved HRT. Compounded products can have variable potency and lack FDA oversight. What each term means Bioidentical hormones: chemically identical to human hormones (example: 17β‑estradiol, micronized progesterone). These can be made as FDA‑approved products (tablets, patches, gels, vaginal rings) or as custom compounds from compounding pharmacies. Standard HRT: a broader category that includes FDA‑approved estradiol products (patches, gels, pills) and FDA‑approved micronized progesterone, synthetic progestins (e.g., medroxyprogesterone acetate) and animal‑derived estrogens (e.g., conjugated equine estrogens). These are manufactured drugs with standardized dosing and safety testing. Examples (brand names and why they matter) FDA‑approved, bioidentical examples: Prometrium (micronized progesterone) — FDA‑approved bioidentical progesterone used to protect the uterus when systemic estrogen is given. Estradiol patches/gels: Vivelle‑Dot, Climara, Alora — deliver 17β‑estradiol transdermally and have standardized dosing. Bijuva — an FDA‑approved combined oral capsule containing estradiol and progesterone (bioidentical combination). Vaginal products: Estrace cream, Vagifem tablets, Estring/Femring (vaginal ring/locally acting estradiol) — useful for local symptoms with lower systemic exposure. Non‑bioidentical / synthetic examples: Premarin (conjugated equine estrogens) — animal‑derived estrogen mixture, historically common. Provera (medroxyprogesterone acetate) — synthetic progestin. Compounded “bioidentical” creams or troches: made by compounding pharmacies to a custom dose. These are not FDA‑approved and product strength/purity can vary. If you choose this route, use a PCAB‑accredited compounding pharmacy (look up PCAB accreditation). Examples of well‑known compounding suppliers/pharmacies in the U.S. include Wedgewood Pharmacy and Fagron (as suppliers/compounding networks) — but check current accreditation and reputation locally. Safety, evidence, and regulation FDA‑approved HRT products have known dosages, standardized manufacturing, and have been evaluated for quality and safety. Long‑term risks (breast cancer, cardiovascular disease, stroke, blood clots) depend on the type of hormone, dose, route (oral vs transdermal), whether progesterone is given, and your personal risk factors. The Women’s Health Initiative (WHI) showed increased risks with combined conjugated equine estrogen + medroxyprogesterone in older participants. Risk profiles differ with estradiol vs conjugated equine estrogens and with micronized progesterone vs synthetic progestins. Compounded bioidenticals: proponents claim “natural” = safer, but there’s no high‑quality evidence that compounded BHRT reduces long‑term risks. Because compounded products aren’t FDA‑reviewed, potency and purity can be inconsistent and they may lack safety data. Testing and monitoring Beware of clinics that base dosing on saliva tests or single spot hormone levels — hormone levels fluctuate and those tests are not reliable for routine dosing. Appropriate approach: evaluate symptoms, medical history, family history (breast cancer, clotting disorders), baseline screening (mammogram, blood pressure, lipids, glucose as needed), then choose a therapy and monitor symptoms and side effects regularly. Use the lowest effective dose for the shortest needed time, and use uterine protection (progesterone or a progestin) if you have a uterus and take systemic estrogen. Practical guidance / when to prefer one option If you want the assurance of standardized dosing and known safety data, choose FDA‑approved products (e.g., estradiol patches, oral estradiol, Prometrium, Bijuva). Consider local vaginal estrogen (Estrace cream, Vagifem, Estring) for primarily vaginal dryness/urginal symptoms — these have lower systemic exposure. If you have unusual needs (allergies to excipients, very specific dose requests), a compounding pharmacy can be considered — but insist on a reputable, PCAB‑accredited pharmacy and understand the tradeoffs (no FDA approval, variable evidence). Discuss the choice with a clinician experienced in menopause/HRT care (board‑certified gynecologist or endocrinologist). Trusted resources: North American Menopause Society (NAMS), Mayo Clinic, Cleveland Clinic for patient information and evidence‑based guidance. Bottom line “Bioidentical” describes the molecular structure of the hormone; the clinically important distinction is whether the product is an FDA‑approved, standardized medication or a custom, non‑FDA‑regulated compounded product. FDA‑approved bioidentical options (Prometrium, estradiol patches/creams, Bijuva) give predictable dosing and safety data; compounded BHRT may be useful in select cases but carries more uncertainty. Talk with a clinician about your symptoms, risks, and monitoring plan before starting HRT.

Mentioned in position 5 of 13

Read full answer with sources →
ClaudeJun 12, 2026, 10:16 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

Bioidentical Hormone Replacement Therapy (BHRT): What You Should Know What Doctors Generally Say Medical opinion is mixed and nuanced: Mainstream medical organizations (like the FDA and Endocrine Society) have concerns: Compounded BHRT lacks rigorous safety testing "Natural" doesn't automatically mean safer Marketing claims often outpace the evidence Many practitioners do support FDA-approved bioidentical options, noting they may have a favorable safety profile compared to synthetic hormones. The Important Distinction Type Examples Status FDA-approved bioidenticals Estradiol patches, Prometrium Tested, regulated Custom compounded BHRT Pellets, custom creams Less regulated, variable quality Reputable Options Doctors Often Recommend Bijuva - FDA-approved estradiol/progesterone combo Prometrium - bioidentical progesterone pill Vivelle-Dot - estradiol patch, widely prescribed Menopause Society (NAMS) certified practitioners for guidance Bottom Line Consult a board-certified endocrinologist or OB-GYN Risks vary by age, health history, and hormone type The Menopause Society (nams.org) has a provider finder tool Would you like more detail on any specific aspect?

Mentioned in position 1 of 3

Read full answer with sources →
ClaudeJun 11, 2026, 20:07 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

Managing Hot Flashes & Sleep Issues at 47 You're likely in perimenopause, and there are several good options: Medical Treatments (Most Effective) Hormone Therapy (HRT/MHT) Vivelle-Dot or Climara (estrogen patches) – well-studied, highly effective Bijuva – combined estrogen/progesterone oral pill Talk to your OB/GYN or a menopause specialist (find one at menopause.org) Non-Hormonal Prescriptions Veozah (fezolinetant) – newer FDA-approved drug specifically for hot flashes Brisdelle (paroxetine) – low-dose antidepressant approved for hot flashes Telehealth Options Midi Health – specializes in perimenopause/menopause care Alloy Women's Health – online menopause prescriptions Evernow – similar menopause-focused platform Sleep Support Magnesium Glycinate (brands: Thorne or Pure Encapsulations) – helps sleep quality Oura Ring – tracks sleep to identify patterns Lifestyle Cognitive Behavioral Therapy for Insomnia (CBT-I) via app Sleepio Cooling mattress pads like Eight Sleep ⚕️ Please consult a doctor – especially to determine if HRT is appropriate for you personally.

Mentioned in position 3 of 14

Read full answer with sources →

Public AI visibility history

Daily rank of Bijuva on our buyer intent questions, per category. A dash means the engines did not cite Bijuva at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Menopause and women's health#25#16
BHRT#62

TL;DR

Bijuva is a branded bioidentical hormone therapy product (an estradiol and progesterone combination oral capsule) that surfaces in AI-generated answers about menopause and women's health. On the WellRank index it currently ranks 12th in the Menopause and Women's Health category with 8% AI visibility, and every mention captured in the WellRank corpus carries a positive tone, suggesting AI engines treat it as a credible option within the hormone therapy conversation.

Company Overview

Bijuva is a prescription hormone therapy product rather than a standalone company in the traditional sense; the domain bijuvargheseassociates.com appears to belong to a separate professional services firm and is not the official product site for the therapy itself. The Bijuva hormone capsule was developed and is marketed by TherapeuticsMD, a pharmaceutical company focused on women's health. The business model centers on prescription pharmaceutical sales through licensed healthcare providers and specialty pharmacies.

Product Features

  • Oral capsule combining estradiol and progesterone in a single dose
  • Bioidentical hormone formulation designed to mirror naturally occurring hormones
  • Indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause
  • Progesterone component is intended to protect the uterine lining, removing the need for a separate progestin prescription
  • FDA-approved combination hormone therapy product

Target Market

Bijuva is prescribed to postmenopausal women who have a uterus and are experiencing moderate to severe hot flashes and other vasomotor symptoms. It is approved and marketed in the United States. Its target prescribers include OB-GYNs, menopause specialists, and primary care physicians treating perimenopausal and postmenopausal patients.

Buyer Personas

  • A perimenopausal woman in her late 40s seeking a single-capsule hormone solution to manage disruptive hot flashes without juggling multiple prescriptions.
  • A postmenopausal patient whose physician prefers a bioidentical hormone option over synthetic progestin-based therapies.
  • An OB-GYN or menopause specialist looking for an FDA-approved combination HRT that simplifies patient adherence.
  • A women's health-conscious consumer who has researched hormone therapy online and asks her doctor specifically about bioidentical options she encountered in AI or editorial content.

Funding & Performance

Bijuva is a product of TherapeuticsMD, which was a publicly traded company; specific current funding stage, revenue figures, or valuation details related to the Bijuva product line are not publicly disclosed in granular form.

Recent Developments

TherapeuticsMD has undergone strategic restructuring in recent years, and the commercial trajectory of Bijuva has been subject to those corporate changes. Broader market interest in bioidentical and combination hormone therapies has grown alongside increased public attention to menopause care, which may be contributing to Bijuva's organic appearance in AI-generated answers. No specific recent product launches or label updates are confirmed here beyond what is widely reported.

Competitive Landscape

Within the WellRank co-mention data, Bijuva appears alongside established hormone therapy brands including Vivelle-Dot and Climara (both transdermal estradiol patches), Prometrium (an oral micronized progesterone), and Vagifem (a vaginal estradiol tablet). It also co-appears with Veozah, a non-hormonal vasomotor symptom treatment, Wedgewood Pharmacy for compounded hormone alternatives, and Thorne for supplement-based approaches. This cluster places Bijuva squarely in the FDA-approved prescription HRT segment, where it differentiates on the convenience of a single bioidentical combination capsule. Resources from The Menopause Society frequently inform the context in which these brands are compared by AI engines.

Bijuva vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Bijuva logo
BijuvaThis brand
#16
8.3%
Vivelle-Dot logo
Vivelle-Dot

3 shared answers

#6
16.7%
Climara logo
Climara

2 shared answers

#7
16.7%
Prometrium logo
Prometrium

2 shared answers

#9
16.7%
Alora logo
Alora

1 shared answers

#29
8.3%

Email me when overtakes Bijuva

One email the day the ranks flip. Nothing else.

User Sentiment

All three AI-engine mentions of Bijuva captured in the WellRank corpus are positive, with zero neutral or cautious references, indicating that when AI systems cite Bijuva they frame it favorably, typically as a convenient and bioidentical-aligned option. Broader patient sentiment in online menopause communities tends to reflect interest in bioidentical formulations, which likely supports this tone. No significant negative signal appears in the current WellRank snapshot.

Pricing

Pricing for Bijuva is not published in a standardized way and varies depending on insurance coverage, pharmacy benefit managers, and patient assistance programs. Patients are generally advised to check with their pharmacy or the manufacturer's savings program for out-of-pocket cost information.

Sources cited around Bijuva

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track Bijuva weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at Bijuva? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.

    Bijuva: AI visibility report | WellRank